[{"Assets_0_Q2_USD":218782000.0,"NetIncomeLoss_2_Q2_USD":17285000.0,"NetIncomeLoss_1_Q2_USD":8797000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1856.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1857.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1853.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1852.0,"StockholdersEquity_0_Q2_USD":198057000.0,"EarningsPerShareBasic_2_Q2_USD":9.33,"EarningsPerShareBasic_1_Q2_USD":4.75,"EarningsPerShareDiluted_2_Q2_USD":9.31,"EarningsPerShareDiluted_1_Q2_USD":4.74,"Ticker":"ATRI","CIK":"701288","name":"ATRION CORP","OfficialName":"Atrion Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1317175511.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]